FDA — authorised 21 November 2001
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: approved
🇺🇸 Invanz in United States
FDA authorised Invanz on 21 November 2001
Marketing authorisations
FDA — authorised 21 November 2001
- Application: NDA021337
- Marketing authorisation holder: MSD SUB MERCK
- Local brand name: INVANZ
- Indication: INJECTABLE — INTRAMUSCULAR, INTRAVENOUS
- Status: approved
Invanz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Invanz approved in United States?
Yes. FDA authorised it on 21 November 2001; FDA authorised it on 21 November 2001.
Who is the marketing authorisation holder for Invanz in United States?
MERCK SHARP DOHME holds the US marketing authorisation.